These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1683260)

  • 1. Influence of pregnancy on dipeptidyl peptidase IV activity (CD 26 leukocyte differentiation antigen) of circulating lymphocytes.
    Mentlein R; Staves R; Rix-Matzen H; Tinneberg HR
    Eur J Clin Chem Clin Biochem; 1991 Aug; 29(8):477-80. PubMed ID: 1683260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assay of dipeptidyl peptidase IV activity in human serum and serum of pregnant women with glycyl-L-proline-1-naphthylamide and other glycyl-L-proline-arylamides as substrates.
    Krepela E; Kasafírek E; Vicar J; Kraml J
    Physiol Bohemoslov; 1983; 32(4):334-45. PubMed ID: 6353449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipeptidyl peptidase IV (CD26) on human lymphocytes. Synthetic inhibitors of and antibodies against dipeptidyl peptidase IV suppress the proliferation of pokeweed mitogen-stimulated peripheral blood mononuclear cells, and IL-2 and IL-6 production.
    Reinhold D; Bank U; Bühling F; Neubert K; Mattern T; Ulmer AJ; Flad HD; Ansorge S
    Immunobiology; 1993 Aug; 188(4-5):403-14. PubMed ID: 7902330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptidyl peptidase IV of human lymphocytes. Evidence for specific hydrolysis of glycylproline p-nitroanilide in T-lymphocytes.
    Schön E; Demuth HU; Barth A; Ansorge S
    Biochem J; 1984 Oct; 223(1):255-8. PubMed ID: 6149745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of dipeptidyl peptidase IV (CD26) from human lymphocytes.
    De Meester I; Vanhoof G; Hendriks D; Demuth HU; Yaron A; Scharpé S
    Clin Chim Acta; 1992 Sep; 210(1-2):23-34. PubMed ID: 1358482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dipeptidyl peptidase IV of peripheral blood lymphocytes in patients with primary biliary cirrhosis].
    Adler D; Kürktschiev D; Subat S; Lehmann HU; Schentke KU
    Z Gastroenterol; 1993 Feb; 31(2):135-9. PubMed ID: 8096665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminopeptidase P and dipeptidyl peptidase IV activity in human leukocytes and in stimulated lymphocytes.
    Hendriks D; De Meester I; Umiel T; Vanhoof G; van Sande M; Scharpé S; Yaron A
    Clin Chim Acta; 1991 Feb; 196(2-3):87-96. PubMed ID: 1674239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipeptidyl amino peptidase IV cytochemistry in circulating lymphocytes from HIV-I-seropositive subjects.
    De Pasquale A; Ginaldi L; Limoncelli P; Quaglino D
    Acta Haematol; 1989; 81(1):19-21. PubMed ID: 2564713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A kinetic fluorometric assay of dipeptidyl peptidase IV in viable human blood mononuclear cells.
    Sedo A; Krepela E; Kasafírek E
    Biochimie; 1989 Jun; 71(6):757-61. PubMed ID: 2568856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of human T lymphocytes identified by antibodies to dipeptidyl peptidase IV on differentiation of human B lymphocytes stimulated with Staphylococcus aureus Cowan I and pokeweed mitogen.
    Gruber M; Scholz W; Flad HD
    Cell Immunol; 1988 May; 113(2):423-34. PubMed ID: 2896071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV.
    Tanaka T; Duke-Cohan JS; Kameoka J; Yaron A; Lee I; Schlossman SF; Morimoto C
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3082-6. PubMed ID: 7909158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipeptidyl peptidase IV in patients with systemic lupus erythematosus.
    Stancíková M; Lojda Z; Lukác J; Ruzicková M
    Clin Exp Rheumatol; 1992; 10(4):381-5. PubMed ID: 1356680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipeptidyl peptidase IV in human T lymphocytes. Impaired induction of interleukin 2 and gamma interferon due to specific inhibition of dipeptidyl peptidase IV.
    Schön E; Demuth HU; Eichmann E; Horst HJ; Körner IJ; Kopp J; Mattern T; Neubert K; Noll F; Ulmer AJ
    Scand J Immunol; 1989 Feb; 29(2):127-32. PubMed ID: 2564215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptidyl peptidase IV in human lymphocytes: molecular properties.
    de Meester I; Vanhoof G; Scharpé S; Hendriks D; van Sande M; Yaron A
    Biochem Soc Trans; 1990 Aug; 18(4):671-2. PubMed ID: 1980467
    [No Abstract]   [Full Text] [Related]  

  • 15. Dipeptidyl peptidase IV in the immune system. Effects of specific enzyme inhibitors on activity of dipeptidyl peptidase IV and proliferation of human lymphocytes.
    Schön E; Born I; Demuth HU; Faust J; Neubert K; Steinmetzer T; Barth A; Ansorge S
    Biol Chem Hoppe Seyler; 1991 May; 372(5):305-11. PubMed ID: 1678607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of the T cell activation monoclonal antibody Ta1 to dipeptidyl peptidase IV.
    Barton RW; Prendergast J; Kennedy CA
    J Leukoc Biol; 1990 Oct; 48(4):291-6. PubMed ID: 1975616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum.
    Mentlein R; Gallwitz B; Schmidt WE
    Eur J Biochem; 1993 Jun; 214(3):829-35. PubMed ID: 8100523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD26 antigen is a surface dipeptidyl peptidase IV (DPPIV) as characterized by monoclonal antibodies clone TII-19-4-7 and 4EL1C7.
    Ulmer AJ; Mattern T; Feller AC; Heymann E; Flad HD
    Scand J Immunol; 1990 Apr; 31(4):429-35. PubMed ID: 1970666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipeptidyl peptidase IV and alpha-naphthylacetate esterase in human T lymphocytes: cytochemical and biochemical investigations.
    Schön E; Ittenson A; Klemm K; Ansorge S
    Acta Histochem; 1984; 75(2):175-82. PubMed ID: 6151772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipeptidyl peptidase IV as a new surface marker for a subpopulation of human T-lymphocytes.
    Mentlein R; Heymann E; Scholz W; Feller AC; Flad HD
    Cell Immunol; 1984 Nov; 89(1):11-9. PubMed ID: 6386188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.